Senseonics Holdings (SENS) Current Deferred Revenue (2015 - 2018)
Senseonics Holdings (SENS) posted quarterly Current Deferred Revenue of $628000.0 for Q4 2018, up 6877.78% quarter-over-quarter from $9000.0 in Q1 2016.
Senseonics Holdings (SENS) Current Deferred Revenue (2015 - 2018) Analysis & Trends
Senseonics Holdings (SENS) has reported Current Deferred Revenue for 3 consecutive years, with $628000.0 the latest figure, recorded in Q4 2018.
- In Q4 2018, Current Deferred Revenue changed N/A year-over-year to $628000.0; the TTM figure through Dec 2018 stood at $628000.0 (changed N/A YoY), while the FY2018 annual figure was $628000.0, changed N/A from the prior year.
- Current Deferred Revenue rose to $628000.0 in Q4 2018 per SENS's latest filing, from $9000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $628000.0 in Q4 2018 and bottomed at $7000.0 in Q4 2015.
- Historically, Current Deferred Revenue has averaged $214666.7 across 3 years, with a median of $9000.0 in 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Senseonics Holdings | 518.56 Mn | 277.95 Mn | 8.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 628,000.00 |
| Mar 31, 2016 | 9,000.00 |
| Dec 31, 2015 | 7,000.00 |